Siemens Healthineers is splitting its Asia Pacific operations into two to allow both China and the rest of the region to achieve their full potential. China, now its own region, continues to be headed by Jerry Wang, while the new Asia Pacific Japan region is headed by Vy Tran, formerly Varian's chief compliance and quality officer.
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, announced two new advances in MR-only workflows to advance head and neck cancer radiotherapy imaging and simulation. The company's artificial intelligence (AI) enabled MRCAT Head and Neck radiotherapy application, which allows the use of MR as the sole or primary imaging modality for radiotherapy planning in the treatment of soft tissue tumors in the head and neck, along with the brain, pelvis and prostate, has received FDA 510(k) clearance and is commercially available in the U.S.
Siemens Healthineers and UHealth - University of Miami Health System - announced a Value Partnership(1) agreement. This strategic relationship will further technological advancement and standardization of equipment at the health system, while allowing the university to create educational and training programs for clinicians and technologists. This unique agreement is the first of its kind in Florida.
A team led by investigators at Massachusetts General Hospital (MGH) recently developed an artificial intelligence - based method to predict which patients are most likely to experience a recurrence and are therefore expected to benefit from aggressive treatment.
Through the Horizon Europe Programme (Artificial Intelligence and Robotics), the AI4Europe project, led by Irish University College Cork (UCC) has been awarded €9 million to develop the platform.
Shared care record and population health management provider Orion Health has a new chief executive. Brad Porter will lead the transition to a new phase for the business after 30 years of Ian McCrae at the helm.
Speaking during his first visit to the United Kingdom in his new role, Porter said: "The UK has always been an important market for Orion Health globally and we remain committed to our UK partners and customers."